Selective lymphocyte chemokine receptor expression in the rheumatoid joint
- PMID: 11762935
- DOI: 10.1002/1529-0131(200112)44:12<2750::aid-art462>3.0.co;2-c
Selective lymphocyte chemokine receptor expression in the rheumatoid joint
Abstract
Objective: In patients with rheumatoid arthritis (RA), chemokines and their receptors are important for lymphocyte trafficking into the inflamed joint. This study was undertaken to characterize the expression of chemokine receptors CCR1, CCR2, CCR3, CCR4, CCR5, CCR6, CXCR3, and CX3CR1 in normal (NL) peripheral blood (PB), RA PB, and RA synovial fluid (SF).
Methods: Using flow cytometry, immunohistochemistry, and 2-color immunofluorescence, we defined the expression of chemokine receptors on CD3+ T lymphocytes in RA synovial tissue (ST), RA SF, RA PB, and NL PB.
Results: The percentage of CD3+ lymphocytes expressing CCR2, CCR4, CCR5, and CX3CR1 was significantly elevated in RA PB compared with that in NL PB, while the percentage of CD3+ lymphocytes expressing CCR5 was significantly enhanced in RA SF compared with that in NL and RA PB. In contrast, similar percentages of CD3+ lymphocytes in NL PB, RA PB, and RA SF expressed CCR6 and CXCR3. Immunohistochemistry of RA ST showed lymphocyte expression of CCR4, and 2-color immunofluorescence staining revealed RA ST CD3+ lymphocytes intensely immunoreactive for CXCR3, suggesting that these 2 receptors may be particularly important for CD3+ lymphocyte trafficking to the inflamed joint. In comparisons of chemokine receptor expression on naive (CD45RA+) and memory (CD45RO+) CD3+ lymphocytes, there were greater percentages of memory CD3+/CD4+ lymphocytes expressing CCR4, CCR5, and CXCR3 than naive CD3+/CD4+ lymphocytes in RA PB and RA SF, and greater percentages of memory CD3+/CD8+ lymphocytes expressing CCR4, CCR5, and CXCR3 than naive CD3+/CD8+ lymphocytes in RA SF, suggesting receptor up-regulation upon lymphocyte activation. In contrast, percentages of CD3+/CD8+ memory lymphocytes expressing CX3CR1 were significantly less than percentages of naive CD3+/CD8+ lymphocytes in RA PB, suggesting that this receptor may be down-regulated upon lymphocyte activation. A major difference between the RA PB and NL PB groups was significantly more CCR4+ memory leukocytes and memory CCR5+/ CD3+/CD8+ lymphocytes in RA PB than NL PB, further suggesting that these receptors may be particularly important for lymphocyte homing to the RA joint.
Conclusion: These results identify CCR4, CCR5, CXCR3, and CX3CR1 as critical chemokine receptors in RA.
Similar articles
-
Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.Arthritis Rheum. 2001 May;44(5):1022-32. doi: 10.1002/1529-0131(200105)44:5<1022::AID-ANR181>3.0.CO;2-N. Arthritis Rheum. 2001. PMID: 11352233
-
Selective recruitment of CXCR3+ and CCR5+ CCR4+ T cells into synovial tissue in patients with rheumatoid arthritis.Acta Med Okayama. 2006 Jun;60(3):149-57. doi: 10.18926/AMO/30745. Acta Med Okayama. 2006. PMID: 16838043
-
CCR3, CCR5, interleukin 4, and interferon-gamma expression on synovial and peripheral T cells and monocytes in patients with rheumatoid arthritis.J Rheumatol. 2003 Sep;30(9):1928-34. J Rheumatol. 2003. PMID: 12966592
-
A review of the pleiotropic actions of the IFN-inducible CXC chemokine receptor 3 ligands in the synovial microenvironment.Cell Mol Life Sci. 2023 Mar 2;80(3):78. doi: 10.1007/s00018-023-04715-w. Cell Mol Life Sci. 2023. PMID: 36862204 Free PMC article. Review.
-
Chemokines and chemokine receptors in arthritis.Front Biosci (Schol Ed). 2010 Jan 1;2(1):153-67. doi: 10.2741/s53. Front Biosci (Schol Ed). 2010. PMID: 20036936 Free PMC article. Review.
Cited by
-
Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial.Arthritis Res Ther. 2012 Jan 17;14(1):R11. doi: 10.1186/ar3685. Arthritis Res Ther. 2012. PMID: 22251436 Free PMC article. Clinical Trial.
-
Targeting the Chemokine System in Rheumatoid Arthritis and Vasculitis.JMA J. 2020 Jul 15;3(3):182-192. doi: 10.31662/jmaj.2020-0019. Epub 2020 Jul 13. JMA J. 2020. PMID: 33150252 Free PMC article. Review.
-
Role of the C-C chemokine receptor-2 in a murine model of injury-induced osteoarthritis.Osteoarthritis Cartilage. 2017 Jun;25(6):914-925. doi: 10.1016/j.joca.2016.11.004. Epub 2016 Nov 14. Osteoarthritis Cartilage. 2017. PMID: 27856294 Free PMC article.
-
High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis.Arthritis Res Ther. 2003;5(5):R241-52. doi: 10.1186/ar783. Epub 2003 Jun 26. Arthritis Res Ther. 2003. PMID: 12932287 Free PMC article.
-
Leukotrienes, mast cells, and T cells.Arthritis Res Ther. 2003;5(6):288-9. doi: 10.1186/ar1017. Epub 2003 Oct 15. Arthritis Res Ther. 2003. PMID: 14680504 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
